Atlas Trials

A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients

Clinical trial NCT00725855 · UNKNOWN

Trial details

NCT number
NCT00725855
Sponsor
Memory Pharmaceuticals
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2008-08-01
Primary completion
2009-03-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.